LONG FOCUS CAPITAL MANAGEMENT, LLC Lineage Cell Therapeutics, Inc. Transaction History

LONG FOCUS CAPITAL MANAGEMENT, LLC portfolio value:

$243,000
portfolio value

LONG FOCUS CAPITAL MANAGEMENT, LLC quarter portfolio value change:

-28.48%
quarter

Lineage Cell Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares -97K $1.13 215K
Q2 2022 share 0.00% 0 shares 9K $1.58 215K
Q1 2022 share 0.00% 0 shares -196K $1.54 215K
Q4 2021 share Increase 0.00% 215K shares 527K $2.5 215K